Free Trial

Femasys (FEMY) News Today

→ Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad)
Free FEMY Stock Alerts
$1.09
+0.05 (+4.81%)
(As of 04:14 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends
June 8 at 1:42 AM | americanbankingnews.com
Femasys (NASDAQ:FEMY) versus Carmell (NASDAQ:CTCX) Financial Contrast
June 4, 2024 | americanbankingnews.com
Femasys Inc. (NASDAQ:FEMY) Sees Large Decline in Short Interest
May 31, 2024 | americanbankingnews.com
Femasys (NASDAQ:FEMY) Trading 0.9% Higher
May 17, 2024 | finance.yahoo.com
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative
May 17, 2024 | globenewswire.com
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative
May 16, 2024 | finance.yahoo.com
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
May 16, 2024 | globenewswire.com
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Gender Policy Council
May 11, 2024 | markets.businessinsider.com
Femasys’s Buy Rating Affirmed by Analyst Jason McCarthy on FemaSeed’s Market Success and Robust Clinical Trials
May 9, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)
May 9, 2024 | investorplace.com
FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q1 2024
May 9, 2024 | globenewswire.com
Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update
May 7, 2024 | globenewswire.com
Femasys Expands Commercial Management Team with Addition of Experienced New Hires
April 18, 2024 | finance.yahoo.com
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
April 18, 2024 | globenewswire.com
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare Initiatives
April 17, 2024 | msn.com
Femasys (FEMY) Price Target Increased by 5.41% to 9.95
March 31, 2024 | finance.yahoo.com
Femasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
March 28, 2024 | investorplace.com
FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q4 2023
March 28, 2024 | globenewswire.com
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
March 21, 2024 | markets.businessinsider.com
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)
March 21, 2024 | globenewswire.com
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
March 21, 2024 | marketwatch.com
Femasys Discloses Positive Data from FemaSeed Trial
March 20, 2024 | finanznachrichten.de
Femasys Inc.: Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed for the Treatment of Infertility
March 20, 2024 | markets.businessinsider.com
Femasys Announces Positive Data For FemaSeed Trial To Enhance Fertilization In Women
March 20, 2024 | globenewswire.com
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
March 13, 2024 | finance.yahoo.com
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
March 9, 2024 | morningstar.com
Thinking about buying stock in Onespan, Avinger, Lithium Americas, Geron, or Femasys?
March 6, 2024 | finanznachrichten.de
Femasys Inc.: Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
March 6, 2024 | globenewswire.com
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
February 28, 2024 | finanznachrichten.de
Femasys Inc.: Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
February 28, 2024 | finance.yahoo.com
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
February 28, 2024 | globenewswire.com
Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
February 24, 2024 | benzinga.com
Femasys Stock (NASDAQ:FEMY), Short Interest Report
February 12, 2024 | msn.com
T2 Biosystems, Invivyd among healthcare movers
February 7, 2024 | msn.com
Femasys Welcomes New Chief Commercial Officer Mr. Spector
January 23, 2024 | finance.yahoo.com
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
December 27, 2023 | benzinga.com
Femasys Stock (NASDAQ:FEMY) Dividends: History, Yield and Dates
December 15, 2023 | finance.yahoo.com
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine
November 30, 2023 | msn.com
Femasys filed to sell 18.11M shares of common stock for holders
November 30, 2023 | baystreet.ca
Femasys Names New Chief Medical Officer
November 30, 2023 | msn.com
Femasys appoints Liu as its chief medical officer
November 30, 2023 | finance.yahoo.com
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer
November 28, 2023 | seekingalpha.com
Femasys: A Women's Health Medical Devices Company Ready To Turn The Corner
November 28, 2023 | finance.yahoo.com
Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch
November 16, 2023 | markets.businessinsider.com
Femasys (FEMY): Solid Financials and Promising Product Developments Reinforce Buy Rating
November 14, 2023 | finance.yahoo.com
Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update
October 26, 2023 | finance.yahoo.com
Femasys Inc. EU MDR Final Audit Successfully Completed
October 25, 2023 | finance.yahoo.com
Femasys Inc. to Showcase FemBloc and its other Novel Products Advancing Women’s Health at the American Association of Gynecologic Laparoscopic Surgeons
October 24, 2023 | finance.yahoo.com
Femasys (FEMY) to Report Q3 Earnings: What's in the Cards?
October 19, 2023 | finance.yahoo.com
Femasys Inc. Regains Compliance with Nasdaq Listing Requirements
October 11, 2023 | seekingalpha.com
Femasys regains Nasdaq compliance
Get Femasys News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.

Biden Nomination CANCELED? (Ad)

And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.

Click here now to see my urgent election warning.

FEMY Media Mentions By Week

FEMY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FEMY
News Sentiment
▼
0.33

0.76
▲
Average
Medical
News Sentiment

FEMY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FEMY Articles
This Week
▼
3

1
▲
FEMY Articles
Average Week

Get Femasys News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:FEMY) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Moonshot Coins for the Current Crypto Run
Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...
Crypto 101 Media | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
The Most Dangerous Time for 401k Owners
The world's most powerful CEO just issued a grave warning to Americans... "This may be the most dangerous t...
Birch Gold | Sponsored